Cargando…

Two years of Truvada for pre-exposure prophylaxis utilization in the US

INTRODUCTION: Truvada(®) (TVD) was approved in July 2012 by the US FDA for pre-exposure prophylaxis (PrEP) in combination with safer sex practices to reduce the risk of sexually acquired HIV-1 in high-risk adults. This study explores the characteristics of US PrEP users and their prescribers over th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Flash, Charlene, Landovitz, Raphael, Mera Giler, Robertino, Ng, Leslie, Magnuson, David, Bush Wooley, Staci, Rawlings, Keith
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International AIDS Society 2014
Materias:	Poster Sessions – Abstract P198
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225421/ https://www.ncbi.nlm.nih.gov/pubmed/25397476 http://dx.doi.org/10.7448/IAS.17.4.19730

Ejemplares similares

Groupe sanguin ABO et sévérité de la COVID-19 : étude monocentrique
por: Dimassi, Imene, et al.
Publicado: (2021)

Clinical Implications of Myocardial Involvement with Covid 19: A Case Control Study
por: Hegde, Shruti, et al.
Publicado: (2020)

The Impact of the COVID-19 Pandemic on Those with Chronic Pain: Preliminary Findings from the Oklahoma Study of Native American Pain Risk
por: Street, Erin, et al.
Publicado: (2022)

PVA/chitosan hydrogels loaded with octenidine and 2-phenoxyethanol for wound dressings
por: Massarelli, Edoardo, et al.
Publicado: (2021)

Que pensent les diabétiques du vaccin contre le COVID ?
por: Ghram, L., et al.
Publicado: (2021)

Safety analysis of raltegravir/truvada regimen in HIV/HCV co-infected patients without switchback after HCV treatment
por: Ehret, Robert, et al.
Publicado: (2014)

1963. PrEP Significantly Reduces the Rate of New HIV Diagnoses in US Metropolitan Statistical Areas Independent of Treatment as Prevention (2012–2017)
por: Mera-Giler, Robertino M, et al.
Publicado: (2019)

Comparison of Cytokines Levels Among Covid-19 Patients Living at Sea Level and High Altitude
por: Valle-Mendoza, J. Del, et al.
Publicado: (2022)

103. Persistence on F/TDF for HIV Pre-exposure Prophylaxis: Insights from Real-world Evidence
por: Tao, Li, et al.
Publicado: (2020)

Pre-exposure prophylaxis for HIV prevention in women: current perspectives
por: Flash, Charlene A, et al.
Publicado: (2017)

Safety, tolerability and effectiveness of HIV non-occupational prophylaxis in Taiwan
por: Li, Hsing-Chuan, et al.
Publicado: (2014)

Prevention of Vaginal SHIV Transmission in Macaques by a Coitally-Dependent Truvada Regimen
por: Radzio, Jessica, et al.
Publicado: (2012)

The suspected unexpected and serious adverse events of antiretroviral drugs used as HIV prophylaxis in HIV uninfected persons
por: Pietraszkiewicz, Ewa, et al.
Publicado: (2014)

853. Real-World Persistency of Patients Receiving Tenofovir-Based Pre-Exposure Prophylaxis for the Prevention of HIV Infection in the US
por: Oglesby, Alan, et al.
Publicado: (2021)

Lésions acrales chroniques (« orteils COVID ») : un syndrome post-COVID long ?
por: André, Raphaël, et al.
Publicado: (2021)

The absolute lymphocyte count accurately estimates CD4 counts in HIV-infected adults with virologic suppression and immune reconstitution
por: Young, Barnaby, et al.
Publicado: (2014)

PRE-VACCINE COUNSELING TO ASSIST WITH RISK ASSESSMENT PRIOR TO COVID-19 VACCINATION
por: Rosenblum, J., et al.
Publicado: (2022)

Analyse des patients hospitalisés pour COVID-19 lors du premier confinement de 2020 à l'aide de méthodes d'explicabilité
por: Excoffier, J-B., et al.
Publicado: (2022)

Evolution du profil des patients hospitalisés au cours des trois premières vagues de COVID-19 par des techniques d'apprentissage automatique
por: Jung, C., et al.
Publicado: (2022)

Efficacy and safety of TDF+FTC+EFV in naïve patients initiating HAART; an observational study comparing Atripla Vs Truvada/Sustiva exposure
por: Sanchez, Carlos Alberto, et al.
Publicado: (2010)

Immunological non-response and low hemoglobin levels are predictors of incident tuberculosis among HIV-infected individuals on Truvada-based therapy in Botswana
por: Mupfumi, Lucy, et al.
Publicado: (2018)

Impact of etravirine use on hospitalization rates among highly pre-treated failing HIV-1 infected individuals between 2005 and 2011
por: Lacombe, Jean-Marc, et al.
Publicado: (2014)

Correction: Immunological non-response and low hemoglobin levels are predictors of incident tuberculosis among HIV-infected individuals on Truvada-based therapy in Botswana
por: Mupfumi, Lucy, et al.
Publicado: (2018)

Contingency Management Facilitates the Use of Postexposure Prophylaxis Among Stimulant-Using Men Who Have Sex With Men
por: Landovitz, Raphael J., et al.
Publicado: (2014)

Facilitators and barriers to cotrimoxazole and nevirapine prophylaxis among HIV exposed babies: a qualitative study from Harare, Zimbabwe
por: Sibanda, E, et al.
Publicado: (2012)

Slow CD4(+) T-Cell Recovery in Human Immunodeficiency Virus/Hepatitis B Virus-Coinfected Patients Initiating Truvada-Based Combination Antiretroviral Therapy in Botswana
por: Anderson, Motswedi, et al.
Publicado: (2016)

Structural-equation-modelling of the tropism impact on achieving viral suppression within six months in naïve HIV patients
por: Mengoli, Carlo, et al.
Publicado: (2014)

Comparison of HIV-1 drug resistance profiles generated from novel software applications for routine patient care
por: Gonzalez, Dimitri, et al.
Publicado: (2014)

Switching from an EFV-based STR to a RPV-based STR is effective, safe and improves HIV patients health status
por: Maggiolo, Franco, et al.
Publicado: (2014)

Pregnancy outcomes in women growing up with perinatally acquired HIV in the United Kingdom and Ireland
por: Byrne, Laura, et al.
Publicado: (2014)

Who gets single tablet regimens (STR), and why?
por: Tarrier, Laura, et al.
Publicado: (2014)

Lamivudine monotherapy as a safe option for HIV-infected paediatric clients with adherence challenges: new evidence from a large South African cohort
por: Linder, Verena, et al.
Publicado: (2014)

Attitudes of serodiscordant couples towards antiretroviral-based HIV prevention strategies in Kenya: a qualitative study
por: Fowler, Nikola, et al.
Publicado: (2014)

Relationship between innate immunity, soluble markers and metabolic-clinical parameters in HIV+ patients ART treated with HIV-RNA<50 cp/mL
por: Dentone, Chiara, et al.
Publicado: (2014)

APRI and FIB-4 scores are not associated with neurocognitive impairment in HIV-infected persons
por: Libertone, Raffaella, et al.
Publicado: (2014)

Longitudinal comparison of HIV-1 plasma viral load and cellular proviral load
por: Schweitzer, Finja, et al.
Publicado: (2014)

Viral escape in the CNS with multidrug-resistant HIV-1
por: Béguelin, Charles, et al.
Publicado: (2014)

Research on demands and accessibility of health services for AIDS long-surviving patients with AIDS-nonrelated diseases: a survey in central China
por: He, Na, et al.
Publicado: (2014)

Switch to Stribild versus continuation of NVP or RPV with FTC and TDF in virologically suppressed HIV adults: a STRATEGY-NNRTI subgroup analysis
por: Stellbrink, Hans-Juergen, et al.
Publicado: (2014)

Tackling cardiovascular co-morbidities in HIV-positive patients: who, how and where?
por: Rolls, Sophie, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_k934q2nnpeait7oni95hg96lrh